Skip to main content
logo
Prelude Therapeutics Incorporated (PRLD)
NASDAQ: PRLD · Real-Time Price · USD
3.430
+0.070 (2.08%)
At close: Mar 17, 2026, 4:00 PM EDT
3.370
-0.060 (-1.75%)
After-hours: Mar 17, 2026, 5:15 PM EDT

Prelude Therapeutics Revenue

In the year 2025, Prelude Therapeutics had annual revenue of $12.14M with 73.43% growth. Prelude Therapeutics had revenue of $5.64M in the quarter ending December 31, 2025, with 41.00% growth.

Revenue (ttm)
$12.14M
Revenue Growth
+73.43%
P/S Ratio
17.80
Revenue / Employee
$92,672
Employees
131
Market Cap
216.10M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202512.14M5.14M73.43%
Dec 31, 20247.00M--
Dec 31, 2023---
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Keros Therapeutics244.06M
Compugen72.76M
Protalix BioTherapeutics61.84M
Fennec Pharmaceuticals38.79M
MediWound16.96M
Surrozen3.60M
Humacyte1.57M
Revenue Rankings

PRLD News

More News